GAL and plasma cell myeloma: Clinically, gal-1 levels appear lower in primary bone marrow stromal cells (BMSCs) from MM patients with bone disease (MMBD) compared to primary BMSCs from donors without malignant bone marrow involvement (control) or MM patients without myeloma bone disease (MM) (Figure 5B).